Matches in Nanopublications for { ?s ?p "[These results show that direct gene delivery of human tissue kallikrein causes a sustained reduction in systolic blood pressure in genetically hypertensive rats and indicate that the feasibility of kallikrein gene therapy for treating human hypertension should be studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_assertion description "[These results show that direct gene delivery of human tissue kallikrein causes a sustained reduction in systolic blood pressure in genetically hypertensive rats and indicate that the feasibility of kallikrein gene therapy for treating human hypertension should be studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_provenance.
- assertion description "[These results show that direct gene delivery of human tissue kallikrein causes a sustained reduction in systolic blood pressure in genetically hypertensive rats and indicate that the feasibility of kallikrein gene therapy for treating human hypertension should be studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results show that direct gene delivery of human tissue kallikrein causes a sustained reduction in systolic blood pressure in genetically hypertensive rats and indicate that the feasibility of kallikrein gene therapy for treating human hypertension should be studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1311243.RAQ77pUFTnSNKWdU83JbRqias6Ve0g1SOmaYxXP1AZ8jI130_assertion description "[These results show that direct gene delivery of human tissue kallikrein causes a sustained reduction in systolic blood pressure in genetically hypertensive rats and indicate that the feasibility of kallikrein gene therapy for treating human hypertension should be studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311243.RAQ77pUFTnSNKWdU83JbRqias6Ve0g1SOmaYxXP1AZ8jI130_provenance.
- NP827908.RA0m1ey6ITYqpjA8M2HxRHXjwMOQztWZ_UJU_TXeXrApU130_assertion description "[These results show that direct gene delivery of human tissue kallikrein causes a sustained reduction in systolic blood pressure in genetically hypertensive rats and indicate that the feasibility of kallikrein gene therapy for treating human hypertension should be studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827908.RA0m1ey6ITYqpjA8M2HxRHXjwMOQztWZ_UJU_TXeXrApU130_provenance.
- NP1311242.RA0daz-hD9WQs6tyrp9EmJGMhCIqKqODEZjvnQzdibNT0130_assertion description "[These results show that direct gene delivery of human tissue kallikrein causes a sustained reduction in systolic blood pressure in genetically hypertensive rats and indicate that the feasibility of kallikrein gene therapy for treating human hypertension should be studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311242.RA0daz-hD9WQs6tyrp9EmJGMhCIqKqODEZjvnQzdibNT0130_provenance.